Immunologists at the Medical College of Georgia and College of Dental Medicine a Georgia Regents University have developed a method of utilizing autologous [the patient’s own] stem cells to treat Ischemia Reperfusion Injury, a condition in which excessive blood flow to an injury results in severe inflammation and hindered recovery. The stem cells function with a chemical called indoleomine 2,3 Dioxygenase, or IDO, which can regulate the immune response without completely disabling it, allowing the healing process to ensue normally.
Nearly two million Americans are affected by Ischemia Reperfusion Injury every year. With further research, stem cells and IDO can allow patients suffering from a variety of diseases and injuries to avoid reperfusion trauma, resulting in a shorter, improved recovery.
Advances in stem cell based regenerative treatments are creating more effective treatment options for patients suffering from a wide variety of disease, trauma and injury. To learn more about stem cells, and how families can bank their own valuable stem cells by recovering the very powerful dental pulp stem cells during routine dental procedures; such as wisdom teeth extractions or the during the loss of baby teeth, visit StemSave or call 877-783-6728 (877-StemSave) today.
To view the full article, click here.
The Future of Regenerative Medicine is Now™